Providence, RI, United States of America

Beverly A Blazar

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beverly A Blazar. Retrieved from https://idiyas.com/inventor/beverly-a-blazar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Beverly A Blazar - Innovator in Immunoregulatory Factors

Introduction

Beverly A Blazar is a notable inventor based in Providence, RI (US). She has made significant contributions to the field of immunology, particularly through her research on mycoplasma proteins.

Latest Patents

Beverly A Blazar holds a patent for "Polynucleotides encoding a mycoplasma protein involved in cell growth regulation." This patent describes a novel immunoregulatory factor, designated IL-X, which has been isolated from Mycoplasma. The invention also concerns polynucleotides that encode IL-X. The IL-X protein serves as a growth factor for EBV transformed human B lymphocytes and murine helper T lymphocytes. Additionally, the patent outlines methods for raising antibodies to IL-X and cloning IL-X.

Career Highlights

Throughout her career, Beverly has focused on the intersection of molecular biology and immunology. Her work has contributed to a deeper understanding of cell growth regulation and the potential therapeutic applications of mycoplasma proteins.

Collaborations

Beverly A Blazar has collaborated with Andrew C Webb, enhancing the research and development of immunoregulatory factors.

Conclusion

Beverly A Blazar's innovative work in the field of immunology, particularly her patent on IL-X, showcases her dedication to advancing scientific knowledge and potential therapeutic solutions. Her contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…